The reasoning
ECT = a controlled therapeutic generalised seizure induced under general anaesthesia + muscle relaxation with full monitoring — modulating neurotransmission, connectivity, and neuroplasticity (mechanism multifactorial, not single‑transmitter). It is a modern, safe, highly effective procedure — not the uncontrolled caricature.
Indications where ECT is genuinely first‑line
- Severe depression needing rapid response: high suicidality, food/fluid refusal, stupor, psychotic depression, treatment resistance. ECT is the most effective acute treatment for severe depression.
- Catatonia (esp. malignant/benzodiazepine‑refractory) — definitive.
- Severe/treatment‑resistant mania — selected cases.
- NMS/malignant catatonia — an option.
Loading diagram…
Safety, adverse effects, and relapse
Main adverse effects: transient confusion, anterograde and retrograde amnesia (usually improves; some persistent autobiographical gaps — right unilateral placement reduces cognitive load vs bilateral), headache, myalgia, plus anaesthetic risk. Individualised risk–benefit and consent/capacity are central. Relapse is high without continuation treatment → plan continuation pharmacotherapy ± maintenance ECT.
Pitfalls
- Withholding ECT as "last resort" from a suicidal, food‑refusing, or psychotically depressed patient who needs speed.
- No continuation strategy → early relapse.
Pearls
- 🎯 ECT is the most effective acute treatment for severe depression and definitive for catatonia — think of it early when speed matters.
- 🩺 Always pair with a continuation/maintenance plan.